CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
The 2 week fasting blood glucose (FBG) level as a predictor of HbA1c treatment response (HbA1c-TR) to once weekly dulaglutide 1.5 mg in patients with type 2 diabetes (T2DM)
DOI 10.1055/s-0035-1549749
Bibliografische Angaben
Nachweis in CareLit
Autor:innenT Forst, S Gough, G Grunberger, V Pechtner, R Shaginian, H Wang, L Fernandez
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: We assessed whether FBG in patients with T2DM measured early in treatment with the once-weekly GLP-1 receptor agonist dulaglutide 1.5 mg predicts HbA1c-TR. Methods: Post-hoc analyses were conducted for 2 randomized studies in patients assigned to dulaglutide 1.5 mg [AWARD-5 with metformin (N = 304) and AWARD-1 with metformin and pioglitazone). AWARD-5 baseline tertile values were used to categorize FBG…
Zitieren
Zitierempfehlung
T Forst, S Gough, G Grunberger, V Pechtner, R Shaginian, H Wang, L Fernandez (2015) The 2 week fasting blood glucose (FBG) level as a predictor of HbA1c treatment response (HbA1c-TR) to once weekly dulaglutide 1.5 mg in patients with type 2 diabetes (T2DM). Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0035-1549749
Mit CareLit weiterarbeiten